These findings indicated that WTAP and YTHDC1 were overexpressed in patients with epilepsy, while RBM15, CBLL1, YTHDC2, HNRNPC, and RBMX showed decreased expression in patients with epilepsy compared to that in the healthy group. Here, RBMX is linked to epilepsy.